Collaborators, Consultants, Advisors
Team
Background:
Led by Jack Oswald, a successful serial entrepreneur who has built several companies from the ground up in a wide variety of technical fields, the management team at ISOThrive has executed crisply in many areas including R&D, intellectual property creation, product production and scale up, and science collaborations.
We have assembled a world class team of professionals in all areas of required competence: management, commercialization, business development, clinical research, bench science, microbiome analytics, and production engineering.
Founding Team:
Jack Oswald, MBA
ISOThrive Co-Founder, CEO and CTO AB Dartmouth, MBA Harvard. Former company was sold to Motorola. One of the inventors of ISOT-101, Jack is a visionary leader providing overall strategy and direction, scientific and engineering expertise.
Peter Swann, MD
ISOThrive Co-founder and Chief Medical Officer, is a subject matter expert in the fields of prebiotics, probiotics and the microbiome. He is a Board Certified Family Physician with a focus on patient health, wellness and prevention.
Lee R. Madsen II, PhD
ISOThrive Co-founder and Chief Science Officer is one of the world’s leading carbohydrate researchers, one of the inventors of ISOT-101, and head of ISOThrive’s R&D laboratory in Manassas, VA.
John Selling, MD
ISOThrive Co-Founder and Medical Advisor is Clinical Associate Professor of Medicine and Gastroenterology, Stanford Medical School. He has 33 years experience in GI physiology research and practice, with published research in NEJM, Annals of Internal Medicine and Gastroenterology.
Research Collaborators:
We have assembled a collaboration of prominent Universities across the U.S., to study ISOT-101.
Pat Gillevet, PhD
Director of GMU’s Microbiome Analysis Center.
David Johnson, MD
Professor of Medicine and Chief of Gastroenterology (EVMS).
Jeanetta Frye, MD
Assistant Professor (UVA).
John Clarke, MD
Clinical Professor, Medicine - Gastroenterology and Hepatology, Director Esophageal Program (Stanford).
Prakash Gyawali, MD
Professor of Medicine, Director Neurogastroenterology and Motility, Director GI Fellowship Training (Washington University, St. Louis).
Advisors:
Mike Walther (member, board of directors)
His industry experience spans greater than 25-years focused on GI pharmaceuticals, medical devices and diagnostics. He launched two of the most widely prescribed proton pump inhibitors (PPIs), Prevacid and Dexilant, for the treatment of gastroesophageal reflux disease (GERD).
Christian Barnes, MPA (business development)
He is a former global business development director, Nestle Health Science.
Additional Company Advisors:
Barb Stuckey (Food Science)
President and Chief Innovation Officer at Mattson, a California food development firm.
Karl P. Ronn (Strategy Advisor)
He has 30 years’ prior experience at Procter & Gamble, where he was responsible for Global R&D for Pharmaceuticals and Over-the-Counter Health Care including Actonel, Vicks, Prilosec, and In-home Diagnostic Tests.
Mark Klopp (Business Advisor)
Former Managing Director of Eastman Ventures, Eastman Chemical Company's corporate venture capital arm.
Contact Us
Looking for more information about ISOThrive? Submit your email below, and we will reach out to you!